{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:16:00Z","timestamp":1793254560990,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000124","name":"Office of Research on Women&apos;s Health","doi-asserted-by":"publisher","award":["P50 MH 68036"],"award-info":[{"award-number":["P50 MH 68036"]}],"id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["P50 MH-77928"],"award-info":[{"award-number":["P50 MH-77928"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ajog.2014.01.005","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T04:36:34Z","timestamp":1389155794000},"page":"270.e1-270.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antiemetic medications in pregnancy: a prospective investigation of obstetric and neurobehavioral outcomes"],"prefix":"10.1016","volume":"210","author":[{"given":"Margaret B.","family":"Larrimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafisa K.","family":"Dajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9824-6612","authenticated-orcid":false,"given":"Eric R.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Eswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Jeffrey","family":"Newport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary N.","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2014.01.005_bib1","first-page":"CD000145","article-title":"Interventions for nausea and vomiting in early pregnancy (Cochrane Review). Chichester, UK: John Wiley & Sons, Ltd","volume":"4","author":"Jewell","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2014.01.005_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.gtc.2011.03.009","article-title":"Nausea and vomiting of pregnancy","volume":"40","author":"Lee","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.ajog.2014.01.005_bib3","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMcp1003896","article-title":"Nausea and vomiting in pregnancy","volume":"363","author":"Niebyl","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.01.005_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects","volume":"94","author":"Anderka","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2014.01.005_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02246074","article-title":"The role of\u00a0the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: antagonist correlation analysis","volume":"121","author":"Fiorella","year":"1995","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.ajog.2014.01.005_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0026-895X(25)14176-X","article-title":"Dopamine D2 receptor binding sites for agonists. A tetrahedral model","volume":"28","author":"Seeman","year":"1985","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.ajog.2014.01.005_bib7","series-title":"Basic & clinical pharmacology","article-title":"Drugs used in the treatment of gastrointestinal diseases","author":"McQuaid","year":"2012"},{"key":"10.1016\/j.ajog.2014.01.005_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2006.07.010","article-title":"Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"88","author":"Zhang","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.ajog.2014.01.005_bib9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1212\/WNL.45.7.1305","article-title":"Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist","volume":"45","author":"Zoldan","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ajog.2014.01.005_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archgenpsychiatry.2012.160","article-title":"Prenatal antipsychotic exposure and neuromotor performance during infancy","volume":"69","author":"Johnson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ajog.2014.01.005_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0748233708089003","article-title":"A\u00a0study of the potential teratogenic effect of large doses of promethazine used for a suicide attempt by 32 pregnant women","volume":"24","author":"Petik","year":"2008","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.ajog.2014.01.005_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0892-0362(98)00043-9","article-title":"The effect of diazepam and promethazine treatment during pregnancy on the somatic development of human offspring","volume":"21","author":"Czeizel","year":"1999","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.ajog.2014.01.005_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.01.005_bib14","series-title":"Neonatal Behavioral Assessment Scale","author":"Brazelton","year":"1995"},{"key":"10.1016\/j.ajog.2014.01.005_bib15","series-title":"Manual for the ASEBA preschool forms and profiles","author":"Achenbach","year":"2000"},{"key":"10.1016\/j.ajog.2014.01.005_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00006250-200404000-00045","article-title":"ACOG practice bulletin. Nausea and vomiting of pregnancy","volume":"103","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.01.005_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/cpt196345628","article-title":"The effects of drugs used in pregnancy on the fetus and newborn","volume":"4","author":"Moya","year":"1963","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.ajog.2014.01.005_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200645040-00006","article-title":"Placental transfer of ondansetron during early human pregnancy","volume":"45","author":"Siu","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2014.01.005_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1345\/aph.1G282","article-title":"No more than necessary: safety and efficacy of low-dose promethazine","volume":"40","author":"Moser","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajog.2014.01.005_bib20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/AOG.0b013e3181d99290","article-title":"Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial","volume":"115","author":"Tan","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.01.005_bib21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9378(96)70607-5","article-title":"A\u00a0pilot study of intravenous ondansetron for hyperemesis gravidarum","volume":"174","author":"Sullivan","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.01.005_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2013.04.017","article-title":"Antihistamines and other prognostic factors for adverse outcome in hyperemesis gravidarum","volume":"170","author":"Fejzo","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2014.01.005_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1471-0528.2008.01701.x","article-title":"Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation","volume":"115","author":"Newport","year":"2008","journal-title":"British Journal of Obstetrics and Gynecology"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:32:35Z","timestamp":1762079555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937814000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0002937814000167"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2014.01.005","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiemetic medications in pregnancy: a prospective investigation of obstetric and neurobehavioral outcomes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2014.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}